Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01475747 · ClinicalTrials.gov registry record
Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 595
- Enrollment target
NCT01475747: Completed study, sponsored by University of Utah.
NCT01475747 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 595 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01475747 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 595 participants
- Enrollment target
Study Summary
Systolic Pressure Intervention Trial (SPRINT) is a large scale randomized trial of \~ 9250 adults aged 50 years or older with high cardiovascular risk sponsored by NIH. The study is designed to recruit 45% of the study population with Chronic Kidney Disease (CKD). The trial will test the effects of low systolic blood pressure (SBP) goal of \< 120 mm Hg versus the standard goal of \< 140 mm Hg on the primary composite of cardiovascular events and death. One of the pre-specified secondary outcome is the progression of kidney disease. In this ancillary named SPRINT - Factors affecting Atherosclerosis STudy (FAST), the investigators plan to take advantage of the unique opportunities afforded by the parent study to examine issues that are of significant public health importance. This is an observational study in SPRINT participants. This study will examine mechanistically, the factors affecting the progression of atherosclerosis in CKD.
Primary Outcome
Correlation of the presence of CKD and rate of progression of atherosclerosis as assessed by magnetic resonance imaging (MRI) of the carotid artery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 595 participants |
| Start Date | 2011-09 |
| Est. Completion | 2018-12 |
What the finished NCT01475747 record still lists
NCT01475747 is an observational study that tracks outcomes without assigning an intervention. The registered 595 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01475747 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01475747 about?
NCT01475747 is a clinical study titled "Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study". Systolic Pressure Intervention Trial (SPRINT) is a large scale randomized trial of \~ 9250 adults aged 50 years or older with high cardiovascular risk sponsored by NIH. The study is designed to recruit 45% of the study population with Chronic Kidney Disease (CKD). The trial will test the effects of ...
What is the current status of trial NCT01475747?
This trial is currently completed. The enrollment target is 595 participants. The study started on 2011-09. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT01475747?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05723198 · 595 participants · Phase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
- NCT02138734 · 596 participants · Phase 1
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
- NCT06797245 · 596 participants · NA
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
- NCT07100080 · 596 participants · Phase 2
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia